XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2023
STOCK-BASED COMPENSATION PLANS  
Schedule of outstanding and exercisable number of options

As of December 31, 2023, the Company had the following stock options outstanding and exercisable:

    

    

Outstanding Number of Options

Exercisable Number of Options

(in thousands)

(in thousands)

Plan Category

 

  

 

  

2005 Stock Option Plan

 

2

2

2017 Stock Option Plan

 

347

347

Total

 

349

349

Summary of Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions during the year ended December 31, 2022.

Weighted average expected term

    

3 years

Weighted average volatility

 

73

%

Weighted average risk-free interest rate

 

2.81

%

Dividend yield

 

0

%

Schedule of stock-based compensation expenses recorded in the condensed consolidated statements of operations

The following table summarizes stock-based compensation expenses recorded in the condensed consolidated statements of income (in thousands):

 

For the Years Ended December 31, 

    

2023

    

2022

Cost of Revenue

$

34

$

47

Sales and marketing expense

 

253

 

191

General, and administrative

2,009

2,104

Total stock-based compensation expense

$

2,296

$

2,342

Schedule of stock option activity under all equity compensation plans

Weighted-

Weighted-

Average

Aggregate

Number of 

Average

Remaining

Intrinsic

Shares

Exercise

Contractual

Value

    

(in thousands)

    

Price

    

Term (Years)

    

(in thousands)

Outstanding at December 31, 2021

 

765

$

1.36

4.68

 

5,896

Granted

 

200

$

6.23

 

Exercised

 

(157)

$

0.66

 

Forfeited

 

(15)

$

4.18

 

Outstanding at December 31, 2022

 

793

$

2.67

5.03

$

8,908

Granted

 

$

 

Forfeited

(206)

$

6.30

Exercised

 

(238)

$

0.79

 

Outstanding at December 31, 2023

 

349

$

1.82

4.12

$

3,163

Exercisable at December 31, 2023

 

349

$

1.82

4.12

$

3,163

Summary of stock options outstanding under the plans

    

Outstanding

    

Weighted average

    

    

    

    

    

Remaining

    

    

Number of

Remaining

Exercisable

 Exercisable

Weighted Average

Options

Contractual

Weighted Average

 Number of

Contractual 

Exercisable

Range

(in thousands)

Life (years)

Strike Price

Options (in thousands)

Life (years)

Strike Price

$0 to $2.00

 

145

3.43

0.43

145

3.43

0.43

$2.01 to $4.00

 

198

4.59

2.66

198

4.59

2.66

$4.01 to $10.00

 

6

5.72

8.13

6

5.72

8.13

 

349

 

4.12

$

1.82

 

349

 

4.12

$

1.82

Schedule of our unvested stock options

    

Non-vested

    

    

Shares

Weighted

Under

Average

Option

Grant Date

(in thousands)

Fair Value

Non-vested at December 31, 2021

 

95

$

3.85

Granted

 

200

 

6.23

Vested

 

(49)

 

4.12

Forfeited

 

(9)

 

5.49

Non-vested at December 31, 2022

 

237

$

5.90

Granted

 

 

Vested

 

(31)

 

3.18

Forfeited

 

(206)

 

6.30

Non-vested at December 31, 2023

 

$

Schedule of restricted stock award activity under all equity compensation plans

Number of

Shares

 

Weighted Average

    

(in thousands)

    

Grant Date Fair Value

Outstanding at December 31, 2021

 

454

$

13.69

Granted

 

194

8.52

Forfeited

 

(165)

12.90

Vested

 

(52)

10.60

Outstanding at December 31, 2022

431

$

11.92

Granted

286

9.54

Forfeited

(13)

11.13

Vested

(202)

11.56

Outstanding at December 31, 2023

 

502

$

10.73